Cell Biotech Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.033x

Cell Biotech Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Cell Biotech Co. Ltd (049960) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.15 Billion ≈ $2.81 Million USD) by net assets (₩127.11 Billion ≈ $86.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Cell Biotech Co. Ltd (2011–2024)

Cash flow conversion efficiency of Cell Biotech Co. Ltd from 2011 to 2024. This chart illustrates how Cell Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Cell Biotech Co. Ltd (049960) share price today for real-time trading data and today's change.

Cell Biotech Co. Ltd Cash Flow Conversion Ratio Explained

Cell Biotech Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Cell Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cell Biotech Co. Ltd ranked by their cash flow conversion efficiency. Also see Cell Biotech Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Karel Elektronik Sanayi ve Ticaret AS IS:KAREL	0.171x
Starry Sea Acquisition Corp Ordinary Shares NASDAQ:SSEA	-0.025x
Telechips Inc KQ:054450	0.019x
Quantum Foods Holdings JSE:QFH	0.032x
DY Power Corp KO:210540	0.044x
Atrium Real Estate Investment Trust KLSE:5130	0.029x
Q.BEYOND AG NA O.N. KONV. XETRA:QBY0	0.002x
Maxiparts Ltd AU:MXI	0.065x

Annual Cash Flow Conversion Efficiency for Cell Biotech Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Cell Biotech Co. Ltd from 2011 to 2024. Review how much free cash does Cell Biotech Co. Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩124.17 Billion ≈ $84.15 Million	₩19.27 Billion ≈ $13.06 Million	0.155x	+122.14%
2023-12-31	₩111.89 Billion ≈ $75.82 Million	₩7.82 Billion ≈ $5.30 Million	0.070x	-41.08%
2022-12-31	₩108.09 Billion ≈ $73.25 Million	₩12.81 Billion ≈ $8.68 Million	0.119x	-15.07%
2021-12-31	₩106.69 Billion ≈ $72.30 Million	₩14.89 Billion ≈ $10.09 Million	0.140x	+45.93%
2020-12-31	₩99.98 Billion ≈ $67.76 Million	₩9.56 Billion ≈ $6.48 Million	0.096x	-3.14%
2019-12-31	₩103.60 Billion ≈ $70.21 Million	₩10.23 Billion ≈ $6.93 Million	0.099x	-25.37%
2018-12-31	₩105.62 Billion ≈ $71.58 Million	₩13.98 Billion ≈ $9.47 Million	0.132x	-47.02%
2017-12-31	₩90.20 Billion ≈ $61.12 Million	₩22.53 Billion ≈ $15.27 Million	0.250x	+16.83%
2016-12-31	₩84.15 Billion ≈ $57.03 Million	₩17.99 Billion ≈ $12.19 Million	0.214x	-19.39%
2015-12-31	₩68.76 Billion ≈ $46.60 Million	₩18.24 Billion ≈ $12.36 Million	0.265x	+40.17%
2014-12-31	₩52.36 Billion ≈ $35.48 Million	₩9.91 Billion ≈ $6.71 Million	0.189x	-9.37%
2013-12-31	₩43.05 Billion ≈ $29.17 Million	₩8.99 Billion ≈ $6.09 Million	0.209x	+23.25%
2012-12-31	₩36.42 Billion ≈ $24.68 Million	₩6.17 Billion ≈ $4.18 Million	0.169x	-1.36%
2011-12-31	₩31.77 Billion ≈ $21.53 Million	₩5.45 Billion ≈ $3.70 Million	0.172x	--

About Cell Biotech Co. Ltd

KQ:049960 Korea Biotechnology & Medical Research

Market Cap

$78.69 Million

₩116.11 Billion KRW

Market Cap Rank

#19941 Global

#1043 in Korea

Share Price

₩15040.00

Change (1 day)

+0.07%

52-Week Range

₩11500.00 - ₩18110.00

All Time High

₩56579.38